Views Differ On Australian Proposal To Link Review Of CDx With Drugs
Executive Summary
Australian proposal to establish a regulatory framework for companion diagnostics has drawn a mixed response from pharmaceutical, biotech and medtech companies on issues like concurrent evaluation, product classification and unique identification.
You may also be interested in...
Australia Wants To Link Regulatory Review Of CDx And Associated Drugs
Therapeutic Goods Administration proposals say the review of companion diagnostics and their corresponding drugs should be linked.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EMA Hopes New Requirement Will Make Companies Stick To Their Filing Plans
An additional form that marketing authorization applicants must now complete during the pre-submission stage emphasizes the importance of companies providing accurate information on their intended submission date.